Cummings, BB;
Marshall, JL;
Tukiainen, T;
Lek, M;
Donkervoort, S;
Foley, AR;
Bolduc, V;
... MacArthur, DG; + view all
(2017)
Improving genetic diagnosis in Mendelian disease with transcriptome sequencing.
Science Translational Medicine
, 9
(386)
10.1126/scitranslmed.aa15209.
Preview |
Text
nihms884236.pdf - Accepted Version Download (983kB) | Preview |
Abstract
Exome and whole-genome sequencing are becoming increasingly routine approaches in Mendelian disease diagnosis. Despite their success, the current diagnostic rate for genomic analyses across a variety of rare diseases is approximately 25 to 50%. We explore the utility of transcriptome sequencing [RNA sequencing (RNA-seq)] as a complementary diagnostic tool in a cohort of 50 patients with genetically undiagnosed rare muscle disorders. We describe an integrated approach to analyze patient muscle RNA-seq, leveraging an analysis framework focused on the detection of transcript-level changes that are unique to the patient compared to more than 180 control skeletal muscle samples. We demonstrate the power of RNA-seq to validate candidate splice-disrupting mutations and to identify splice-altering variants in both exonic and deep intronic regions, yielding an overall diagnosis rate of 35%. We also report the discovery of a highly recurrent de novo intronic mutation in COL6A1 that results in a dominantly acting splice-gain event, disrupting the critical glycine repeat motif of the triple helical domain. We identify this pathogenic variant in a total of 27 genetically unsolved patients in an external collagen VI–like dystrophy cohort, thus explaining approximately 25% of patients clinically suggestive of having collagen VI dystrophy in whom prior genetic analysis is negative. Overall, this study represents a large systematic application of transcriptome sequencing to rare disease diagnosis and highlights its utility for the detection and interpretation of variants missed by current standard diagnostic approaches.
| Type: | Article |
|---|---|
| Title: | Improving genetic diagnosis in Mendelian disease with transcriptome sequencing |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1126/scitranslmed.aa15209 |
| Publisher version: | https://doi.org/10.1126/scitranslmed.aa15209 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Cell Biology, Medicine, Research & Experimental, Research & Experimental Medicine, NEUROMUSCULAR DISEASES, MUSCULAR-DYSTROPHIES, SPLICING SIGNALS, ENHANCERS ESES, RNA-SEQ, VARIANTS, MUTATIONS, OPPORTUNITIES, CHALLENGES, PREDICTION |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Neurosciences Dept |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10055859 |
Loading...
Loading...Loading...Loading...Archive Staff Only
 |
View Item |
